SINAGRA, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 79.346
EU - Europa 55.961
AS - Asia 46.725
SA - Sud America 6.138
AF - Africa 1.323
OC - Oceania 177
Continente sconosciuto - Info sul continente non disponibili 63
Totale 189.733
Nazione #
US - Stati Uniti d'America 77.735
IT - Italia 19.029
SG - Singapore 16.810
CN - Cina 10.693
PL - Polonia 7.454
RU - Federazione Russa 5.159
BR - Brasile 4.656
VN - Vietnam 4.599
HK - Hong Kong 4.496
SE - Svezia 4.179
DE - Germania 3.929
UA - Ucraina 2.928
FR - Francia 2.855
KR - Corea 2.795
GB - Regno Unito 2.213
BD - Bangladesh 2.194
FI - Finlandia 1.958
NL - Olanda 1.816
TR - Turchia 1.203
IN - India 1.047
BG - Bulgaria 1.001
IE - Irlanda 982
CA - Canada 806
AR - Argentina 521
JP - Giappone 498
CH - Svizzera 456
MX - Messico 437
ES - Italia 397
AT - Austria 362
MA - Marocco 333
IQ - Iraq 309
ID - Indonesia 291
ZA - Sudafrica 273
PK - Pakistan 207
EC - Ecuador 198
BE - Belgio 195
CO - Colombia 187
SA - Arabia Saudita 181
VE - Venezuela 159
EG - Egitto 150
CL - Cile 146
AU - Australia 145
SN - Senegal 145
PH - Filippine 143
RO - Romania 140
IR - Iran 124
GR - Grecia 121
CZ - Repubblica Ceca 112
UZ - Uzbekistan 101
AE - Emirati Arabi Uniti 100
PT - Portogallo 96
TH - Thailandia 91
PE - Perù 88
KE - Kenya 85
MY - Malesia 85
PY - Paraguay 85
LT - Lituania 84
DZ - Algeria 81
KZ - Kazakistan 80
JO - Giordania 79
IL - Israele 71
TW - Taiwan 68
HU - Ungheria 67
AZ - Azerbaigian 60
TN - Tunisia 60
DK - Danimarca 52
UY - Uruguay 52
CR - Costa Rica 51
JM - Giamaica 50
NP - Nepal 50
OM - Oman 48
RS - Serbia 47
EU - Europa 43
LV - Lettonia 43
PA - Panama 42
BO - Bolivia 41
SI - Slovenia 39
HR - Croazia 37
KG - Kirghizistan 37
AL - Albania 36
HN - Honduras 35
TT - Trinidad e Tobago 35
ET - Etiopia 32
SK - Slovacchia (Repubblica Slovacca) 29
DO - Repubblica Dominicana 28
LB - Libano 27
NZ - Nuova Zelanda 27
NI - Nicaragua 26
MD - Moldavia 25
NO - Norvegia 25
BY - Bielorussia 24
GE - Georgia 24
QA - Qatar 24
LK - Sri Lanka 23
TG - Togo 23
KW - Kuwait 21
NG - Nigeria 21
GT - Guatemala 20
SV - El Salvador 20
AO - Angola 19
Totale 189.324
Città #
Singapore 9.774
Ashburn 9.563
Fairfield 6.299
Warsaw 6.280
San Jose 5.130
Woodbridge 5.088
Chandler 4.761
Hong Kong 4.342
Houston 3.962
Moscow 3.927
Ann Arbor 3.751
Wilmington 2.980
Seoul 2.728
Seattle 2.706
Jacksonville 2.687
Hefei 2.623
Beijing 2.330
Trieste 2.181
Cambridge 2.150
Milan 1.886
Chicago 1.648
Boardman 1.636
Princeton 1.528
Ho Chi Minh City 1.424
Los Angeles 1.348
Rome 1.204
Dallas 1.182
Council Bluffs 1.092
Lauterbourg 1.064
Hanoi 1.003
Zgierz 992
Sofia 979
Columbus 968
Helsinki 955
Dublin 951
Santa Clara 890
Izmir 877
New York 846
Munich 718
The Dalles 696
London 671
Buffalo 655
Frankfurt am Main 633
Naples 476
São Paulo 474
Dearborn 420
San Diego 382
Turin 336
Amsterdam 329
Bologna 329
Tokyo 312
Düsseldorf 306
Orem 283
Bern 276
Shanghai 253
Da Nang 250
Montreal 250
Florence 248
Nuremberg 238
Grafing 237
Casablanca 233
Phoenix 231
Redondo Beach 230
Lappeenranta 224
Guangzhou 218
Toronto 218
Atlanta 205
Vienna 202
Verona 201
Washington 196
Chennai 180
Palermo 180
Haiphong 171
Denver 170
Brussels 166
Bari 164
Falls Church 161
Bremen 160
Brooklyn 160
Dong Ket 160
Miano 160
Redwood City 158
Turku 152
Catania 148
Genoa 148
Nanjing 146
Dakar 144
Rio de Janeiro 144
Salt Lake City 143
Mumbai 142
Des Moines 139
Tianjin 137
Jinan 136
Venezia 136
Venice 136
Johannesburg 135
Udine 134
Padova 128
Stockholm 128
Mexico City 126
Totale 121.157
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis. 3.335
Linee guida sullo scompenso cardiaco a confronto: AHA 2022 versus ESC 2021 2.039
Inquadramento e gestione della pericardite costrittiva: revisione critica 1.913
Continuità assistenziale ospedale-territorio per il paziente con scompenso cardiaco cronico: Una rivoluzione e una sfida nella cura ambulatoriale 1.161
Documento di consenso ANMCO/FADOI/SIAARTI/SIC/SIMG/SIMI/SIMEU: Il percorso clinico-diagnostico e terapeutico del paziente con scompenso cardiaco acuto dal domicilio alla dimissione dal Pronto Soccorso/ Dipartimento di Emergenza-Accettazione 842
Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library 721
Il Registro Regionale delle Morti Cardiache Improvvise in età giovanile del Friuli Venezia Giulia. Protocolli operativi e risultati di un progetto multidisciplinare 631
ECG come “red flag” e potenziale predittore prognostico (2) 584
Iperpotassiemia nello scompenso cardiaco: nuove soluzioni per un vecchio problema 548
A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies 508
Cardiac fluid dynamics meets deformation imaging 480
Does Ectopic Beats Bring More Discriminatory Information to Diagnose Ischemic Heart Disease? 471
Arresto cardiaco extraospedaliero: le competenze degli studenti dell’Università degli Studi di Trieste sulle manovre rianimatorie e l’utilizzo del defibrillatore automatico esterno 465
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study 456
Glomerular filtration rate: A prognostic marker in atrial fibrillation-A subanalysis of the AntiThrombotic Agents Atrial Fibrillation 453
Elevations of inflammatory markers PTX3 and sST2 after resuscitation from cardiac arrest are associated with multiple organ dysfunction syndrome and early death 437
Consulenza cardiologica e gestione perioperatoria del paziente cardiopatico. Protocollo dell’Azienda Sanitaria Universitaria Integrata di Trieste – Anno 2019 437
Natural History of Dilated Cardiomyopathy in Children 434
Routine use of bilateral internal thoracic artery grafts for left-sided myocardial revascularization in insulin-dependent diabetic patients: early and long-term outcomes 427
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias 427
Role of Titin Missense Variants in Dilated Cardiomyopathy 424
Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes. 416
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 408
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 407
Miocardite, cardiomiopatia infiammatoria e perimiocardite: possiamo fare ordine? 406
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist? 406
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures 402
Exercise performance, haemodynamics, and respiratory pattern do not identify heart failure patients who end exercise with dyspnoea from those with fatigue 397
Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction 385
Protocolli cardiologici per il giudizio di idoneità allo sport agonistico (COCIS) 2023 384
FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy 384
MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs 383
Facciamo il punto: miocardio non compatto 382
Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy 382
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives 376
Takotsubo is not a cardiomyopathy 371
I dieci punti che il cardiologo deve conoscere su scintigrafia miocardica con traccianti ossei, amiloidosi e cuore 370
Implantable cardioverter-defibrillator-computed respiratory disturbance index accurately identifies severe sleep apnea: The DASAP-HF study 366
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 366
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 361
Conflicting gender-related differences in the natural history of patients with idiopathic dilated cardiomyopathy 361
Multi-state modelling of heart failure care path: A population-based investigation from Italy 360
Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure 357
Acromegalic Cardiomyopathy With Malignant Arrhythmogenic Pattern Successfully Treated With Mechanical Circulatory Support and Heart Transplantation 352
Right Ventricular Strain and Dyssynchrony Assessment in Arrhythmogenic Right Ventricular Cardiomyopathy: Cardiac Magnetic Resonance Feature-Tracking Study 347
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy 340
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 338
Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial 334
Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction 334
La fibrillazione atriale non valvolare: dati dall’Osservatorio delle Malattie Cardiovascolari della provincia di Trieste [Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)] 332
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 328
A predictive scoring system for deep sternal wound infection after bilateral internal thoracic artery grafting 327
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 327
Factor-V HR2 haplotype and thromboembolic disease 326
Malfunction of cardiac devices after radiotherapy without direct exposure to ionizing radiation: Mechanisms and experimental data 325
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 324
Documento di consenso Società Italiana di Cardiologia- Società Italiana di Nefrologia: Ruolo dell’asse cardio-renale nella prevenzione e trattamento delle patologie cardiovascolari – Parte II: Dalle strategie di prevenzione al trattamento del paziente con coinvolgimento cardio-renale 323
Impact of Aging on Heart Rate Variability Properties of Healthy Subjects 319
Critical role of lysosomes in the dysfunction of human Cardiac Stem Cells obtained from failing hearts 318
PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity 318
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 310
Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy 308
Genome-wide association meta-analysis of 30,000 samples identifies seven novel loci for quantitative ECG traits 308
Aortoaxillary bypass during cardiac operation. 307
Deleterious impact of mild anemia on survival of young adult patients (age 45 ± 14 years) with idiopathic dilated cardiomyopathy: data from the Trieste Cardiomyopathies Registry. 306
Adipokines, Ghrelin and Obesity-Associated Insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome. 304
Left Ventricular Response to Cardiac Resynchronization Therapy: Insights From Hemodynamic Forces Computed by Speckle Tracking 304
Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6 303
Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy 302
Preoperative Intra-Aortic Counterpulsation in Cardiac Surgery: Insights From a Retrospective Series of 588 Consecutive High-Risk Patients 301
Long-term outcome of 'super-responder' patients to cardiac resynchronization therapy. 299
Riabilitazione cardiologica ambulatoriale a Trieste: Protocolli, attività  ed esiti 299
Reference Values for Peak Exercise Cardiac Output in Healthy Individuals 299
Contemporary etiology and prognosis of dilated non-ischemic cardiomyopathy 297
Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? 295
U-shaped relationship between vitamin D levels and long-term outcome in large cohort of survivors of acute myocardial infarction 295
Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction 293
Dieci quesiti in tema di miocardite eosinofila [Ten questions about eosinophilic myocarditis] 290
n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial. 289
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 287
Infiltrative/storage cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 283
Simple scoring system to predict in-hospital mortality after surgery for infective endocarditis 283
Com'è cambiata la storia naturale della cardiomiopatia dilatativa? 281
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 281
Persistence of vitamin D deficiency among Italian patients with acute myocardial infarction 280
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 280
The peculiar role of vitamin D in the pathophysiology of cardiovascular and neurodegenerative diseases 279
Unraveling the relationship among insulin resistance, IGF-1, and amyloid-beta 1–40: Is the definition of type 3 diabetes applicable in the cardiovascular field? 278
Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial. 276
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 276
Chapter 13: Current Management and Treatment 276
Prognostic impact of short-term changes of E/E' ratio and left atrial size in dilated cardiomyopathy 274
Historical Terminology, Classifications, and Present Definition of DCM. 274
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 273
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 273
Cardiopulmonary Responses and Prognosis in Hypertrophic Cardiomyopathy. A Potential Role for Comprehensive Noninvasive Hemodynamic Assessment 271
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 270
A risk factor analysis for in-hospital mortality after surgery for infective endocarditis and a proposal of a new predictive scoring system 268
Characterization of Cardiac Function by Echocardiographic Global Longitudinal Strain in a Cohort of Children with Neurofibromatosis Type 1 Treated with Selumetinib 267
Predictors of immediate and long-term outcomes of coronary bypass surgery in patients with left ventricular dysfunction 267
Totale 42.741
Categoria #
all - tutte 556.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 556.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229.804 426 761 561 767 423 928 412 392 1.222 1.010 778 2.124
2022/202316.247 1.300 1.768 1.285 2.146 1.444 2.587 378 1.503 1.802 402 1.012 620
2023/202414.319 1.021 873 749 1.000 1.274 1.266 1.879 2.154 262 639 1.826 1.376
2024/202530.442 1.645 2.273 2.625 2.849 2.552 2.823 1.573 1.715 3.197 3.567 2.495 3.128
2025/202671.729 6.760 4.023 5.552 6.440 5.827 5.960 9.224 2.751 7.738 9.293 4.732 3.429
2026/2027124 124 0 0 0 0 0 0 0 0 0 0 0
Totale 193.858